This resource series, curated by the BGS Cardiovascular SIG, brings together key principles and guidelines on the management of cardiovascular disease in older adults.
Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure for the treatment of severe aortic stenosis which aims to provide a less invasive alternative to surgery. This involves inserting a new valve through a catheter, usually by way of a large blood vessel at the top of the leg, into the heart and inside the existing faulty aortic valve.
Key guidelines
- Transcatheter aortic valve implantation for aortic stenosis: Interventional procedures guidance [IPG586] - National Institute for Health and Care Excellent (NICE)
National standard evidence-based recommendations for aortic stenosis.
- Guidelines for the management of valvular heart disease (2017) - ESC/EACTS
This guideline provides comprehensive, practical, evidence-based recommendations for the diagnosis and management of patients with significant aortic valve disease.
- Joint Statement on clinical selection for Trans-catheter Aortic Valve Implantation (TAVI) 2017 - On behalf of BCS and BCIS
This statement summarises the views of the British Cardiovascular Society (BCS), Society for Cardiothoracic Surgery (SCTS), and the British Cardiovascular Intervention Society (BCIS) on how patients with aortic valve disease should be treated and which patients are best suited to TAVI, on the basis of current evidence.
- Service Specification for TAVI - BCIS
Recommendations of the British Cardiovascular Intervention Society (BCIS).
